Kewaunee Scientific (NASDAQ:KEQU) Announces Earnings Results

Key Points

• Kewaunee Scientific reported quarterly EPS of $0.58, with a 3.41% net margin and 14.10% return on equity.
• The stock fell 2.7% to $35.03 during Wednesday trading, well below its 52-week high of $57.88; the company’s market capitalization was approximately $100.5 million.
• Institutional investors own 32.69% of the company, while the sole tracked analyst maintains a Hold rating.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) announced its quarterly earnings results on Wednesday. The technology company reported $0.58 earnings per share (EPS) for the quarter, Zacks reports. Kewaunee Scientific had a net margin of 3.41% and a return on equity of 14.10%.

Kewaunee Scientific Stock Down 2.7%

KEQU stock traded down $0.98 during mid-day trading on Wednesday, hitting $35.03. The stock had a trading volume of 3,205 shares, compared to its average volume of 4,652. The company has a fifty day moving average of $36.77 and a 200 day moving average of $37.19. Kewaunee Scientific has a 1-year low of $33.27 and a 1-year high of $57.88. The stock has a market capitalization of $100.47 million, a price-to-earnings ratio of 10.88 and a beta of 0.73. The company has a current ratio of 2.18, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53.

Institutional Trading of Kewaunee Scientific

Several large investors have recently added to or reduced their stakes in the business. Bank of America Corp DE raised its holdings in shares of Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after purchasing an additional 443 shares in the last quarter. US Bancorp DE raised its holdings in Kewaunee Scientific by 80.0% during the third quarter. US Bancorp DE now owns 900 shares of the technology company's stock valued at $38,000 after buying an additional 400 shares in the last quarter. Raymond James Financial Inc. bought a new position in Kewaunee Scientific during the second quarter valued at about $60,000. Barclays PLC acquired a new stake in shares of Kewaunee Scientific in the fourth quarter worth about $92,000. Finally, Jane Street Group LLC boosted its stake in shares of Kewaunee Scientific by 65.8% during the 1st quarter. Jane Street Group LLC now owns 8,052 shares of the technology company's stock worth $317,000 after acquiring an additional 3,196 shares in the last quarter. 32.69% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a "hold (c)" rating on shares of Kewaunee Scientific in a research report on Tuesday, June 30th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of "Hold".

About Kewaunee Scientific

Kewaunee Scientific Corporation NASDAQ: KEQU is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.